To elucidate the role of these pathways in the tumorigenesis of NSCLC, we have determined the protein expression levels of key players in NSCLC, including EGFR, pAKT, pERK, and p53, as prognostic biomarkers in early-stage NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.